Status:

COMPLETED

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

Lead Sponsor:

Sun Yat-sen University

Collaborating Sponsors:

Ministry of Education, China

Guangdong Science and Technology Bureau, China

Conditions:

Type 2 Diabetes Mellitus

Eligibility:

All Genders

25-70 years

Phase:

NA

Brief Summary

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemic agents) on...

Detailed Description

ß-Cell dysfunction and decreased insulin sensitivity are the main pathophysiological defects responsible for the development of hyperglycemia. With continuous presence of insulin resistance, progressi...

Eligibility Criteria

Inclusion

  • informed consents be given before treatment
  • the newly-diagnosed type 2 diabetic patients
  • fasting blood glucose (FBG) level ranging from 7.0~16.7 mmol/L
  • age ranging from 25~70 years old
  • body mass index (BMI) ranging from20~35kg/m2
  • never be treated with any anti-hyperglycemic agents or anti-hyperlipidemic agents

Exclusion

  • having any severe acute or chronic complications
  • renal dysfunction, blood creatinine≥150µmol/L
  • blood aminotransferase level rising up(more than 2 times of the normal level)
  • any severe cardiac disease including congestive cardiac failure, unstable angina and myocardial infarct in 12 months
  • serious hypertension (systolic pressure≥180mmHg and/ or diastolic pressure≥110mmHg)
  • chronic or acute pancreatic disease
  • severe systematic diseases or malignant tumor
  • allergic to the drugs using in the trial
  • any factors interfering the result
  • female patients incline to be pregnant
  • being treated with corticosteroid, immunosuppressing drugs or cytotoxic drugs
  • poor compliance

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2007

Estimated Enrollment :

436 Patients enrolled

Trial Details

Trial ID

NCT00147836

Start Date

September 1 2004

End Date

October 1 2007

Last Update

April 1 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the first Affiliated Hospital of Sun Yat-Sen university

Guangzhou, Guangdong, China, 510080